Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: Denmark Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20172
20191
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Recruiting3
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Incyte Corporation1
Institut de Recherches Internationales Servier1
Novartis Pharmaceuticals1
Revolution Medicines, Inc.1
Seagen Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Neoplasms4
Thyroid Neoplasms4
Breast Neoplasms3
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Colonic Neoplasms3
Endocrine Gland Neoplasms3
Endocrine System Diseases3

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.